New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Scientists have been studying Parkinson’s for many years, but they still don’t fully understand why it happens. Without ...

A team of researchers has discovered that a protein called cypin plays a powerful role in helping brain cells connect and ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

A groundbreaking advancement by a team of scientists in Australia—led by Indian-origin researchers—could dramatically change ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

By shutting down a hyperactive enzyme, scientists got damaged brain cells to regrow their lost “antennae” and restart ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...